It may seem obvious why the online market has such high growth rates, especially considering the events that occurred in the last couple of years and how they pushed people to use the internet for many services, including retail and banking. Similarly, daily and weekly bonuses and promotions have increased registration numbers on online casino sites. So, attributes such as electronic payment options, daily bonuses, and promotions all encourage new and existing players to keep coming back for more. The application of AI in gathering user data on new and returning players has assisted operators and developers in keeping fresh content that maintains relevance while creating targeted marketing campaigns. The bad news for those employees is that they would end up losing work to robots, which means an entire industry would take a hit. It may seem obvious why the online market has such high growth rates, especially considering the events that occurred in the last couple of years and how they pushed people to use the internet for many services, including retail and banking.

The commercialization of AI is playing a positive role in accelerating business digitalization, improving industry chain structures and enhancing information use efficiency. AI has entered an age of machine learning, and the future of AI development will depend on the integration of key technologies and industries. AI investment is returning to reason, with underlying technologies and easy-to-deploy applications more favored by AI leading institutions. The Internet giant has also begun to strategically deploy in the artificial intelligence business related industry. As a new industry in the future, AI enterprises show the characteristics of high growth rate.

According to the new market research report "Artificial Intelligence (AI) in Drug Discovery Market by Component (Software, Service), Technology (ML, DL), Application (Neurodegenerative Diseases, Immuno-Oncology, CVD), End User (Pharmaceutical & Biotechnology, CRO), Region - Global forecast to 2024", published by MarketsandMarkets, the AI in Drug Discovery Market is projected to reach USD 1,434 million by 2024 from USD 259 million in 2019, at a CAGR of 40.8% during the forecast period. Some of the factors responsible for the growth of this market are growing number of cross-industry collaborations and partnerships, the need to control drug discovery & development costs and reduce the overall time taken in this process, the rising adoption of cloud-based applications & services, and the impending patent expiry of blockbuster drugs. On the other hand, a lack of data sets in the field of drug discovery and the inadequate availability of skilled labor are some of the factors challenging the growth of the market. "The services segment is expected to grow at the highest CAGR during the forecast period." On the basis of offering, the Artificial Intelligence in drug discovery market is segmented into software and services.